To help readers find the specific technology they are looking for out of the 700 vendors on the vast expo floor at the ...
A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with ductal carcinoma in situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to new research. Researchers concluded that use of a radiation boost should be considered in DCIS patients who have life expectancies of 10 or more years following breast-conserving surgery and WBRT.
Agfa Healthcare recently announced that its offerings at the 2016 annual meeting of the Radiological Society of North America (RSNA) will center on the theme of “Care You Can See" across the company's entire product portfolio.
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago, including the latest advances in ultrasound.
October 10, 2016 — Novarad’s most recent software development has enabled the company to achieve a bi-directional ...
People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet. The phase 3 randomized trial found that whole brain radiotherapy had no beneficial effect on length or quality of survival over treatment with steroids and other supportive care.
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago.
October 7, 2016 — ContextVision’s US PLUSView 2.0 technology for 2-D ultrasound image enhancement has been extended for ...
October 7, 2016 — Utah-based healthcare technology company Novarad’s most recent software development has enabled the ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
UCHealth (Colorado) has expanded their use of Riverain’s ClearRead Bone Suppression and ClearRead Confirm software to all five of their flagship hospitals. The expansion will ensure patients across the entire network benefit from the same tools designed to aid in more effective detection of lung disease, including lung cancer. Utilization of the ClearRead tools across UCHealth ensures patients and clinicians benefit from the technology independent of the imaging location within the network.
Philips Healthcare featured its latest integrated imaging and treatment planning solutions for radiation oncology at the American Society for Therapeutic Radiology and Oncology’s (ASTRO) 58th Annual Meeting, Sept. 25-28 in Boston. Designed to fit the unique needs of radiation oncology clinicians and patients, these solutions have been developed to put more control in the hands of the clinician, with the intent to improve workflow and operational efficiencies, drive procedure accuracy and ultimately improve care.
Rachael Bennett, clinical analyst for MD Buyline, discusses trends in radiation oncology at ASTRO 2016.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
ASTRO Chairman of the Board David C. Beyer, MD, FASTRO, discusses the current trends in radiation oncology, key trends presented at this year's conference, and achieving value, and opportunities to improve value, in the treatment of prostate cancer.
Medic Vision is exhibiting at the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016) and will be highlighting its SafeCT-29 product.
High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer control rates, according to new research. The findings were presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston. The study is the first large, multi- institutional study of SBRT in prostate cancer with long-term follow-up.
Elekta announced recently that its high-field magnetic resonance linear accelerator (MR-linac) was the focus of multiple presentations at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, held Sept. 25 – 28 in Boston. Additional abstracts presented by members of Elekta’s MR-linac Consortium also highlighted the need for adaptation of radiation therapy to address moving tumors and nearby organs during treatment sessions. Naturally occurring physiological movements currently limit the ability to conform the treatment to the target and increase exposure of radiation to healthy tissues.
October 6, 2016 — Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic ...
Using anonymized data collected by the Radimetrics Enterprise Platform we identified a customer with a contrast dose outlier and initiated an investigation to gain further insight.
aycan recently introduced aycan store VNA, a vendor neutral archiving (VNA) and distribution system that helps healthcare organizations be more efficient with the management and sharing of images and other data.
The American College of Radiology (ACR) announced in a recent statement that if Congress does not act, millions of women may lose insurance coverage for annual mammograms. Patient groups, minority healthcare advocates and breast cancer experts are urging Congress to extend a federal mandate that effectively requires insurers to fully cover annual screening mammograms for women ages 40 and older.
November 23, 2016 